Skip to main content
Erschienen in: Endocrine 1/2017

28.01.2017 | Letter to the Editor

Is the hypothalamic–pituitary–adrenal axis disrupted in type 2 diabetes mellitus and is this relevant for bone health?

verfasst von: Cristina Eller-Vainicher, Alfredo Scillitani, Iacopo Chiodini

Erschienen in: Endocrine | Ausgabe 1/2017

Einloggen, um Zugang zu erhalten

Excerpt

We read with interest the Editorial [1] and the two studies recently published on this Journal [2, 3] regarding the hypothalamic–pituitary–adrenal axis disruption in type 2 diabetes mellitus (T2D) and its consequences on the glycometabolic control. …
Literatur
1.
Zurück zum Zitat H. Raff, S.B. Magill, Is the hypothalamic—pituitary—adrenal axis disrupted in type 2 diabetes mellitus? Endocrine 54(1), 273–275 (2016)CrossRefPubMed H. Raff, S.B. Magill, Is the hypothalamic—pituitary—adrenal axis disrupted in type 2 diabetes mellitus? Endocrine 54(1), 273–275 (2016)CrossRefPubMed
2.
Zurück zum Zitat E.K. Spanakis, X. Wang, B.N. Sanchez, A.V. Diez Roux, B.L. Needham, G.S. Wand, T. Seeman, S.H. Golden, Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis. Endocrine 53(1), 227–239 (2016)CrossRefPubMedPubMedCentral E.K. Spanakis, X. Wang, B.N. Sanchez, A.V. Diez Roux, B.L. Needham, G.S. Wand, T. Seeman, S.H. Golden, Lack of significant association between type 2 diabetes mellitus with longitudinal change in diurnal salivary cortisol: the multiethnic study of atherosclerosis. Endocrine 53(1), 227–239 (2016)CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat G. Bellastella, M.I. Maiorino, A. De Bellis, M.T. Vietri, C. Mosca, L. Scappaticcio, D. Pasquali, K. Esposito, D. Giugliano, Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes. Endocrine 53(1), 220–226 (2016)CrossRefPubMed G. Bellastella, M.I. Maiorino, A. De Bellis, M.T. Vietri, C. Mosca, L. Scappaticcio, D. Pasquali, K. Esposito, D. Giugliano, Serum but not salivary cortisol levels are influenced by daily glycemic oscillations in type 2 diabetes. Endocrine 53(1), 220–226 (2016)CrossRefPubMed
Metadaten
Titel
Is the hypothalamic–pituitary–adrenal axis disrupted in type 2 diabetes mellitus and is this relevant for bone health?
verfasst von
Cristina Eller-Vainicher
Alfredo Scillitani
Iacopo Chiodini
Publikationsdatum
28.01.2017
Verlag
Springer US
Erschienen in
Endocrine / Ausgabe 1/2017
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-017-1237-1

Weitere Artikel der Ausgabe 1/2017

Endocrine 1/2017 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.